论文部分内容阅读
1耐药肺结核发病概况:据估计,全球每年新出现耐多药肺结核病人30~60万。2009中国卫生部指出中国于2007年~2008年在全国范围开展的结核病耐药基线调查结果显示,中国肺结核病病人中耐多药率为8.32%,耐药率为0.68%。据此估算,中国每年新发耐多药肺结核患者12万名,其中80%为农村患者,青壮年患者比例较高,没有性别差异。目前中国结核病年发病人数约为130万,位居全球第2位,仅次于印度。由于流动人口数量增加,公共卫生资源不足、公众重视度不够,在中国则有5.5亿人遭到感染,每年约13万人死于结核病。另
An overview of the incidence of drug-resistant TB: It is estimated that there are between 300,000 to 600,000 new MDR-TB patients in the world each year. 2009 The Chinese Ministry of Health pointed out that a baseline survey of tuberculosis resistance conducted by China in China from 2007 to 2008 showed that the MDR-TB rate in Chinese patients with tuberculosis was 8.32% and the rate of resistance was 0.68%. According to this estimate, 120,000 newly-infected MDR-TB patients are newly diagnosed each year in China, of which 80% are rural patients, with a high proportion of young patients and no gender differences. At present, the number of tuberculosis cases in China is about 1.3 million, ranking second in the world after India. Due to the increase in the number of floating population, inadequate public health resources and insufficient public awareness, 550 million people are infected in China and about 130,000 people die of tuberculosis each year. another